Home > Newsletters > The QMN Weekly Bulletin > Lax Investigations Into Discrepancies Lands A&Z Pharmaceutical a Form 483
The QMN Weekly Bulletin
July 27, 2012 | Vol. 4 No. 30
Lax Investigations Into Discrepancies Lands A&Z Pharmaceutical a Form 483
A&Z Pharmaceutical failed to adequately investigate unexplained discrepancies in drug products tied to compression-related troubles at the company’s Deer Park, N.Y., plant, a Form 483 states. Thorough investigations of “black spots” and “dirt specks” discovered during compression of acetaminophen tablets were not conducted, FDA investigators said in the Nov. 15, 2011, form.
Drug GMP Report
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.